Home › at
 

Keywords :   


Tag: at

Merck to Release Findings from Integrated Analysis of Six Phase 2 and 3 Clinical Trials Evaluating Investigational Elbasvir/Grazoprevir in Patients with Chronic Hepatitis C Genotype 1, 4 or 6 Infection and Compensated Cirrhosis at The Liver Meeting

2015-11-15 01:00:00| Merck.com - Research & Development News

Dateline City: KENILWORTH, N.J. Patients with Compensated Liver Cirrhosis Among Most Difficult-to-Treat KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the presentation of results from an integrated analysis of patients with compensated liver cirrhosis (Child-Pugh class A) from six Phase 2 and 3 clinical trials evaluating the efficacy and safety of the investigational once-daily tablet elbasvir/grazoprevir1 (50mg/100mg) with or without ribavirin (RBV) in patients with chronic hepatitis C virus (HCV) genotypes (GT) 1, 4 or 6 infection. Language: English Contact: MerckMedia:Doris Li, 908-246-5701orSarra Herzog, 201-669-6570orInvestors:Teri Loxam, 908-740-1986orJustin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: the or at release

 

Kenneth Cole handbags are $25 at Hamrick's

2015-11-13 17:14:47| Footwear - Topix.net

Kenneth Cole handbags are $25 at Hamrick's through Saturday, November 14. Take advantage of this amazing deal to choose one for your own winter wardrobe and to get a few to slip under the tree for special women on your holiday gift list. The perfect gift, there's never any need to worry about size, style or color.

Tags: at kenneth cole handbags

 
 

Galena Biopharma to Present Final GALE-401 Phase 2 Clinical Data at...

2015-11-06 19:09:55| Biotech - Topix.net

Galena Biopharma to Present Final GALE-401 Phase 2 Clinical Data at the 57th American Society of Hematology Annual Meeting and Exposition SAN RAMON, Calif., Nov. 6, 2015 -- Galena Biopharma, Inc. , a biopharmaceutical company developing and commercializing innovative, targeted oncology therapeutics that address major medical needs across the full spectrum of cancer care, today announced the final data from the Company's GALE-401 Phase 2 proof-of-concept clinical trial will be presented at the upcoming 57th American Society of Hematology Annual Meeting and Exposition in Orlando, FL.

Tags: at data present final

 

Toyota announces expected fuel economy and pricing for RAV4 Hybrid: 33 mpg combined, entry at $28,370

2015-11-06 18:55:29| Green Car Congress

Tags: at entry expected combined

 

08/12/2015 - BIFM Sheffield & South Yorkshire Group - Networking Event at Sheffield Hallam University

2015-11-04 13:53:36| BIFM Events

For our next meeting we will convene at 5pm on Tuesday 8th December at Sheffield Hallam University, precise venue to be confirmed, for a networking meeting with a very current topic.

Tags: at group south university

 

Sites : [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] next »